Exponent(EXPO)
搜索文档
Exponent(EXPO) - 2020 Q1 - Earnings Call Transcript
2020-05-01 10:11
Exponent, Inc. (NASDAQ:EXPO) Q1 2020 Earnings Conference Call April 30, 2020 4:30 PM ET Company Participants Whitney Kukulka – Investor Relations Catherine Corrigan – President and Chief Executive Officer Rich Schlenker – Executive Vice President and Chief Financial Officer Conference Call Participants Tobey Sommer – SunTrust Trevor Romeo – William Blair Marc Riddick – Sidoti Alexis Huseby – D.A. Davidson Sam England – Berenberg Operator Good day and welcome to the ExponentÂ's First Quarter of Fiscal Year 2 ...
Exponent(EXPO) - 2020 Q4 - Annual Report
2020-02-29 05:45
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended January 3, 2020. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ________ to _________. Commission File Number 0-18655 EXPONENT, INC. | --- | --- | --- | --- | --- | |------------------------------------------------------------------------- ...
Exponent(EXPO) - 2019 Q4 - Earnings Call Transcript
2020-02-07 12:02
Exponent, Inc. (NASDAQ:EXPO) Q4 2019 Results Earnings Conference Call February 6, 2020 4:30 PM ET Company Participants Whitney Kukulka - Investor Relations Dr. Catherine Corrigan - President and CEO Rich Schlenker - Executive Vice President and CFO Conference Call Participants Drew Kootman - Cantor Fitzgerald Alexis Huseby - D.A. Davidson & Company Jasper Bibb - SunTrust Andrew Nicholas - William Blair Marc Riddick - Sidoti Operator Good day. And welcome to the Exponent Fourth Quarter and Fiscal Year 2019 E ...
Exponent(EXPO) - 2019 Q3 - Quarterly Report
2019-11-02 04:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 27, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to___________ Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) DELAWARE 77-0218904 (State ...
Exponent(EXPO) - 2019 Q3 - Earnings Call Transcript
2019-10-18 09:01
Exponent, Inc. (NASDAQ:EXPO) Q3 2019 Earnings Conference Call October 17, 2019 4:30 PM ET Company Participants Whitney Kukulka – Investor Relations Catherine Corrigan – President and Chief Executive Officer Rich Schlenker – Executive Vice President and Chief Financial Officer Conference Call Participants Joseph Foresi – Cantor Fitzgerald Alexis Huseby – D.A. Davidson Andrew Nicholas – William Blair Tobey Sommer – SunTrust Sam England – Berenberg Operator Good day and welcome to the Exponent Third Quarter of ...
Exponent(EXPO) - 2019 Q2 - Quarterly Report
2019-08-03 04:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 28, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to___________ Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) (650) 326-9400 (Registrant's te ...
Exponent(EXPO) - 2019 Q2 - Earnings Call Transcript
2019-07-19 07:21
Exponent, Inc. (NASDAQ:EXPO) Q2 2019 Earnings Conference Call July 18, 2019 4:30 PM ET Company Participants Whitney Kukulka – Investor Relations Catherine Corrigan – President and Chief Executive Officer Rich Schlenker – Executive Vice President and Chief Financial Officer Conference Call Participants Joseph Thompson – SunTrust Drew Kootman – Cantor Fitzgerald Tim McHugh – William Blair Sam England – Berenberg Marc Riddick – Sidoti Operator Good day, and welcome to the ExponentÂ's Second Quarter of Fiscal 2 ...
Exponent(EXPO) - 2019 Q1 - Quarterly Report
2019-05-04 04:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 29, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) DELAWARE 77-0218904 (State or other jurisdiction of (I ...
Exponent(EXPO) - 2019 Q1 - Earnings Call Transcript
2019-04-19 09:10
Exponent, Inc. (NASDAQ:EXPO) Q1 2019 Earnings Conference Call April 18, 2019 4:30 PM ET Company Participants Whitney Kukulka - Investor Relations Catherine Corrigan - President and Chief Executive Officer Richard Schlenker - Executive Vice President and Chief Financial Officer Paul Johnston - Executive Chairman Conference Call Participants Timothy McHugh - William Blair & Company L.L.C., Tobey Sommer - SunTrust Robinson Humphrey Joseph Foresi - Cantor Fitzgerald Securities Samuel England - Berenberg Capital ...
Exponent(EXPO) - 2018 Q4 - Annual Report
2019-02-23 06:29
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 28, 2018. OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ________ to _________. Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) Delaware 77-0218904 (State or other jurisdiction ...